Bayer plans to put $2.2 billion toward the construction of a new drug production site in Ohio, with a starting focus in oncology, cardiovascular and kidney therapies. Described as a modular campus that will span drug substance and product manufacturing, the site outside Columbus in New Albany is slated to create about 600 new jobs.…
AstraZeneca invests $300 million to establish new cell therapy manufacturing facility in Maryland
Maryland Governor Wes Moore announced that AstraZeneca would invest $300 million to construct a new manufacturing facility in Rockville, a city with roughly 70,000 inhabitants that is about 17 miles from Washington, D.C. The facility will focus on cell therapies for cancer treatment. The 84,000 square-foot facility, slated for completion in 2026, will enable global…

